INST MASSONE S A has a total of 14 patent applications. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Argentina. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are XU HANMEI, CYTRAN INC and MILHAUD GERARD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Argentina | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Balanian Liliana Ester | 8 |
#2 | Fasanella Erundina Marta | 6 |
#3 | Groisman Jose Felipe | 5 |
#4 | Wolfenson Band Claudio Fernand | 4 |
#5 | Wolfenson Band Claudio Fernando | 3 |
#6 | Wolfenson Claudio | 3 |
#7 | Groisman José | 3 |
#8 | Cancela Mariana | 3 |
#9 | Balanián Liliana | 3 |
#10 | Castellano Miguel Angel | 2 |
Publication | Filing date | Title |
---|---|---|
EP3145950A1 | A process for obtaining hmg-up (human menopausal gonadotropin with ultra-purity grade) and a composition free of contaminants | |
WO2013118093A1 | Therapeutic method of treatment for inhibiting tumor development using tamm-horsfall glycoprotein (thp) as immunostimulating drug and compositions | |
US7022822B1 | Highly purified gonadotropin compositions and process for preparing them | |
CA2370225A1 | Highly purified gonadotropin compositions and process for preparing them |